Anyanwu M*, Suwareh K, Senghore K, Bah R, Jack M, Jatta M, Touray K, Jallow J, Sumbunu A, Drammeh R, Jorbateh I and Sonko I

Edward Francis Small Teaching Hospital, Banjul, Gambia

*Corresponding Author: Anyanwu M, Edward Francis Small Teaching Hospital, Banjul, Gambia.

Received: April 01, 2024; Published: April 12, 2024

Abstract

Mrs IB presented with 20 years history of inability to conceive despite having regular unprotected, satisfactory intercourse whenever husband comes for vacation. She had a month’s history of vaginal discharge with no other associated symptom. She is married to a 56 year old man in a polygamous marriage. Madame IB’s co-wife has 5 children and her last child birth was 20 years ago.
She has a regular monthly cycle with flow lasting for 3-4 days, no history of contraceptive use or previous miscarriage.
She has been in and out of several health centers with HSG report of bilateral tubal blockage. The husband never did semen analysis on his previous visits as he believed he was normal until four months ago when the couple came to our center. Laparoscopy and chromopertubation was performed which demonstrated bilateral tubal patency with spillage of dyes into the pouch of Douglas. There were neither adhesions nor ovarian pathology. The semen analysis was found to have severe Oligo-astheno-teratozoospermia.
. Holistic evaluation of infertile couple is always recommended. Isolated incomplete evaluation based on assumptions of previous fertile episodes should be discouraged in our practice. Male factor infertility is common the psycho-cultural impact if not addressed may lead to prolong duration of infertility and delays appropriate treatment.

Keywords: HSG; False Positive; Laparoscopy and Dye Test; Male Infertility

References

1. Santulli P., et al. “Oligo-anovulation is not a rarer feature in women with documented endometriosis”. Fertility and Sterility 5 (2018): 941-948.
2. Kashi AM., et al. “The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas”. International Journal of Gynecology and Obstetrics 2 (2017): 200-204.
3. Sarıdoğan E. “Adolescent endometriosis”. The European Journal of Obstetrics and Gynecology and Reproductive Biology 209 (2017): 46-49.
4. Nirgianakis K., et al. “Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study”. Acta Obstetricia et Gynecologica Scandinavica 100.1 (2021): 30-40.
5. Dubrovina SO., et al. “Modern ideas about the diagnosis and treatment of endometriosis”. Obstetrics and Gynecology 2 (2023): 146-153.
6. Busacca M., et al. “Guidelines for diagnosis and treatment of endometriosis”. Italian Journal of Gynaecology and Obstetrics 2 (2018): 7-21.
7. ESHRE Endometriosis Guideline Development Group. Endometriosis”. Guideline of European Society of Human Reproduction and Embryology (2022): 192.
8. Becker CM., et al. “ESHRE Endometriosis Guideline Group”. ESHRE guideline: endometriosis”. Human Reproduction Open2 (2022): hoac009.
9. Becker KM., et al. “Guidelines of the European Society for Human Reproduction, Endometriosis (Ed.V.N. Serova, A.A. Smetnik, S.O. Dubrovina). Obstetrics and Gynecology: News, opinions, training 11.1 (2023): 67-93.
10. Ministry of Health of the Russian Federation. “Endometriosis”. Clinical guidelines. Moscow (2020). (in Russian).
11. Santulli P., et al. “Increased rate of spontaneous miscarriages in endometriosis-affected women”. Human Reproduction 5 (2016): 1014-1023.
12. Chapron C., et al. “Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis”. Human Reproduction 8 (2011): 2028-2035.
13. Bernuit D., et al. “Female perspectives on endometriosis: findings from the uterine bleeding and pain women’s research study”. Journal of Endometriosis 2 (2011): 73-85.
14. Casper RF. “Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills”. Fertility and Sterility 3 (2017): 533-536.
15. Yong PJ., et al. “CHC for pelvic pain in women with endometriosis: ineffectiveness or discontinuation due to side-effects”. Human Reproduction Open 2 (2020): Hoz040.
16. Ulumbekova GE and Khudova IYu. “Demographic, social and economic effects of hormonal therapy in endometriosis and abnormal uterine bleeding. HEALTHCARE MANAGEMENT: News, Views, Education”. Bulletin of VSHOUZ1 (2022): 82-113. (in Russian).
17. Dubrovina SO and Berlim YuD. “Gestagens in the therapy of endometriosis”. Akusherstvo i Ginekologiya/Obstetrics and Gynecology 5 (2018): 150-155.
18. Order of the Ministry of Health of the Russian Federation dated 20.10.2020 № 1130n «On approval of the Procedure for the provision of medical care in the profile of «obstetrics and gynecology» (Registered in the Ministry of Justice of Russia on 12.11.2020 №60869 (in Russian) (2020).
19. Vercellini P., et al. “Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate”. Fertility and Sterility 5 (2005): 1375-1387.
20. Chwalisz K., et al. “The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis”. Reproductive Sciences 6 (2012): 563-571.
21. Schindler AE., et al. “Reprint of classification and pharmacology of progestins”. Maturitas1-2 (2018): 171-180.
22. Africander D., et al. “Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception”. Steroids 7 (2011): 636-652.
23. Kim SE., et al. “The long-term effect of dienogest on bone mineral density after surgical treatment of endometrioma”. Reproductive Sciences 5 (2021): 1556-1562.
24. Backer MHJr. “Isopregnenone (Duphaston): a new progestational agent”. Obstetrics and Gynecology 19 (1962): 724-729.
25. Trivedi P., et al. “Effective post-laparoscopic treatment of endometriosis with dydrogesterone”. Gynecological Endocrinology 1 (2007): 73-76.
26. Johnston WIH. “Dydrogesterone and endometriosis”. BJOG 83 (1976): 77-80.
27. Makhmudova GM., et al. “Efficacy of duphaston treatment in women with endometriosis after reconstructive surgery”. Akusherstvo i Ginekologija (Sofiia)4 (2003): 42-46.
28. Taniguchi F., et al. “The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study”. Journal of Obstetrics and Gynaecology Research 1 (2019): 168-175.
29. Balasch J., et al. “Dehydrogesterone treatment of endometrial luteal phase deficiency after ovulation induced by clomiphene citrate and human chorionic gonadotropin”. Fertility and Sterility 4 (1983): 469-471.
30. Savelyeva GM., et al. “Gynecology. National guideline. 2^nd Moscow: GEOTAR-Media 1048 (2017). (in Russian).
31. Schweppe KW. “The place of dydrogesterone in the treatment of endometriosis and adenomyosis”. Maturitas 1 (2009): S23-27.
32. Sukhikh GT., et al. “Dydrogesterone for the treatment of confirmed endometriosis: key results of an observational open multicenter study in real clinical practice (ORCHIDEA study)”. Obstetrics and gynecology: News, Opinions, Training 4 (2020): 79-81.
33. Dubrovina SO., et al. “Drug therapy in patients with endometrioid cysts ovarian disease in the pre- and postoperative period: a retrospective cohort study”. Obstetrics and Gynecology 5 (2021):
34. Vercellini P., et al. “Medical treatment of endometriosis-related pain”. Best Practice and Research Clinical Obstetrics and Gynaecology 51 (2018): 68-91.
35. Schmeler KM., et al. “Adnexal masses in pregnancy: Surgery compared with observation”. Obstetrics and Gynaecology 5 Pt 1 (2005): 1098-1103.
36. Barbara AG., et al. “Cancer in the pregnant patient. In: Principles and practice of gynecologic oncology”. 3^rd Philadelphia: Lippincott Williams and Wilkins (2000): 501-528.
37. Ueda Y., et al. “A retrospective analysis of ovarian endometriosis during pregnancy”. Fertility and Sterility 1 (2010): 78-84.
38. Pateman K., et al. “Natural history of ovarian endometrioma in pregnancy”. BMC Womens Health 14 (2014): 128.
39. Bailleux M., et al. “Ovarian endometriosis during pregnancy: a series of 53 endometriomas”. The European Journal of Obstetrics and Gynecology and Reproductive Biology 209 (2017): 100-104.
40. Benaglia L., et al. “The vanishing endometrioma: the intriguing impact of pregnancy on small endometriotic ovarian cysts”. Gynecological Endocrinology 9 (2018): 863-866.
41. Leeners B., et al. “The effect of pregnancy on endometriosis – facts or fiction?” Human Reproduction Update 24.3 (2018): 290-29
42. Barbieri M., et al. “Decidualized ovarian endometriosis in pregnancy: a challenging diagnostic entity”. Human Reproduction 8 (2009): 1818-1824.
43. Guerriero S., et al. “Serial ultrasonographic evaluation of a decidualized endometrioma in pregnancy”. Ultrasound in Obstetrics and Gynecology 3 (2005): 304-306.
44. Dubrovina SO., et al. “Positive influence Pregnancy for ovarian endometriosis – real or fiction?” Obstetrics and Gynecology 5 (2020).
45. Dubrovina SO., et al. “Pharmacological Management of Endometriosis-related Pain: The Expert Opinion”. Journal of South Asian Federation of Obstetrics and Gynaecology 6 (2020): 415-420.
46. Liang B., et al. “Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice”. Reproductive Biology and Endocrinology 16.1 (2018):
47. Kim SA., et al. “Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis”. Obstetrics and Gynecology Science 6 (2016): 506-511.
48. Sukhikh GT., et al. “Algorithms for the management of patients with endometriosis: a coordinated position of experts of the Russian Society of Obstetricians and Gynecologists”. Obstetrics and Gynecology 5 (2023): 159-176.
49. Sukhikh GT., et al. “Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study”. Fertility and Sterility 6 (2021): 1568-1577.

Citation

Citation: Anyanwu M., et al. “False Positive Bilateral Tubal Block on Hysterosalpingography and Psycho-Cultural Impact on Male Factor Infertility".Acta Scientific Women's Health 6.5 (2024): 10-13.

Copyright

Copyright: © 2024 Anyanwu M., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.